Literature DB >> 23673584

Tdap vaccination during pregnancy to reduce pertussis infection in young infants.

Jeremy N Matlow, Anna Pupco, Pina Bozzo, Gideon Koren.   

Abstract

QUESTION: What is the basis for the new recommendations to vaccinate pregnant women against pertussis after the first trimester? ANSWER: There have been outbreaks of epidemic proportions of pertussis, mostly among young infants who have not received sufficient passive immunity from their mothers. This strategy of vaccination during pregnancy aims at stopping these life-threatening epidemics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23673584      PMCID: PMC3653651     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

Review 1.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

2.  Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Nicole M Smith; Joseph S Bresee; David K Shay; Timothy M Uyeki; Nancy J Cox; Raymond A Strikas
Journal:  MMWR Recomm Rep       Date:  2006-07-28

3.  Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for persons aged 0 through 18 years--United States, 2013.

Authors:  Iyabode Akinsanya-Beysolow; Renée Jenkins; H Cody Meissner
Journal:  MMWR Suppl       Date:  2013-02-01

Review 4.  Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.

Authors:  Thad R Wilson
Journal:  J Pediatr Health Care       Date:  2006 Jul-Aug       Impact factor: 1.812

5.  Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.

Authors:  Katrina Kretsinger; Karen R Broder; Margaret M Cortese; M Patricia Joyce; Ismael Ortega-Sanchez; Grace M Lee; Tejpratap Tiwari; Amanda C Cohn; Barbara A Slade; John K Iskander; Christina M Mijalski; Kristin H Brown; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-12-15

6.  [Vaccination in parents of young infants survey].

Authors:  F de La Rocque; E Grimprel; J Gaudelus; A Lécuyer; C Wollner; M-C Leroux; R Cohen
Journal:  Arch Pediatr       Date:  2007-10-29       Impact factor: 1.180

7.  Pertussis resurgence in Canada largely caused by a cohort effect.

Authors:  Benoît Ntezayabo; Gaston De Serres; Bernard Duval
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

Review 8.  Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Trudy V Murphy; Barbara A Slade; Karen R Broder; Katrina Kretsinger; Tejpratap Tiwari; Patricia M Joyce; John K Iskander; Kristin Brown; John S Moran
Journal:  MMWR Recomm Rep       Date:  2008-05-30

9.  In utero immunization of the fetus to tetanus by maternal vaccination during pregnancy.

Authors:  Y Vanderbeeken; M Sarfati; R Bose; G Delespesse
Journal:  Am J Reprod Immunol Microbiol       Date:  1985-06

10.  Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.

Authors:  C Mary Healy; Flor M Munoz; Marcia A Rench; Natasha B Halasa; Kathryn M Edwards; Carol J Baker
Journal:  J Infect Dis       Date:  2004-06-14       Impact factor: 5.226

View more
  2 in total

1.  Tdap vaccine during pregnancy.

Authors:  Judy MacDonald
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

Review 2.  The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Authors:  Pier Luigi Lopalco; Frank DeStefano
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.